Related Experiment Video

Updated: Aug 17, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Clinical value of NT-ProBNP and BNP in pediatric cardiology

Amiram Nir1, Nadera Nasser

  • 1Shaare Zedek Medical Centre, Jerusalem, Israel.

Journal of Cardiac Failure
|June 11, 2005
PubMed

Insights

B-type natriuretic peptide (BNP) and NT-proBNP levels are elevated in infants and children with heart disease. These biomarkers can aid in diagnosing pediatric heart conditions and improving clinical care.

Area of Science:

  • Pediatric Cardiology
  • Biomarkers
  • Cardiovascular Health

Background:

  • Heart disease is a significant cause of morbidity and mortality in children.
  • Congenital and acquired heart conditions can lead to heart failure in pediatric populations.
  • Understanding pediatric heart disease requires effective diagnostic tools.

Purpose of the Study:

  • To evaluate the role of natriuretic peptides in pediatric heart disease.
  • To determine if BNP and NT-proBNP can serve as reliable biomarkers in infants and children.
  • To assess the potential of these peptides in improving clinical practice for pediatric cardiology.

Main Methods:

  • Analysis of available data on natriuretic peptide levels in pediatric populations.
  • Comparison of peptide levels in healthy children versus those with heart disease.
  • Correlation of peptide levels with clinical parameters like functional capacity and respiratory distress.

Main Results:

  • Natriuretic peptide levels (BNP and NT-proBNP) are elevated in infants and children with heart disease, particularly with ventricular pressure or volume overload.
  • Peptide levels correlate with functional capacity in children with congestive heart failure.
  • BNP and NT-proBNP can help differentiate cardiac from pulmonary causes of respiratory distress in infants.

Conclusions:

  • NT-proBNP and BNP are validated markers for heart disease in infants and children.
  • The use of these natriuretic peptides shows promise for enhancing clinical practice in pediatric cardiology.
  • Further research may explore their utility in specific pediatric cardiac conditions.
Abstract

More Related Videos

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...